In a unique deal that will create and bankroll 10 new San Diego drug companies, La Jolla investment firm Avalon Ventures has teamed up with British drugmaker GlaxoSmithKline Plc to funnel up to $495 million into new startups over the next three years...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129